Lactose (India) Limited

LACTOSE6

INE058I01013

Food Processing

Market Closed - Bombay S.E. Other stock markets 06:00:54 2024-07-11 am EDT			5-day change	1st Jan Change
179.9 ^INR	+0.50%		-4.61%	+43.35%

Feb. 14	Lactose Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Lactose Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Lactose Limited Appoints Dhaval Jayant Soni as Additional Director (Non-Executive Independent Director)

March 19, 2022 at 05:58 am EDT

Lactose (India) Limited approved the appointment of Mr. Dhaval Jayant Soni as an "Additional Director (Non-Executive Independent Director)" on the Board of Directors of the Company with effect from 19th March, 2022 for a period of 5 years.

Latest news about Lactose (India) Limited

Lactose Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Lactose Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 02	CI
Lactose Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Lactose Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
Lactose Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-30	CI
Lactose Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Lactose Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Lactose Limited Announces Change in Registered Office Address	22-08-09	CI
Lactose Limited Approves Re-Appointment of M/S. Cas & Co. as Statutory Auditors	22-06-17	CI
Lactose Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-17	CI
Lactose (India) Board to Consider Allotment of Equity Shares Upon Warrant Conversion	22-03-23	MT
Lactose Limited Appoints Dhaval Jayant Soni as Additional Director (Non-Executive Independent Director)	22-03-19	CI
Lactose Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI
Lactose Limited Announces the Resignation of Mahendrakumar Singhi Omprakash as Independent Director	21-12-30	CI
Lactose Limited Announces Resignation of Shyamsunder Toshniwal as Director	21-12-21	CI
Lactose Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI
Lactose India Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-12	CI
Lactose (India) : Swings to Profit in Fiscal Q4	21-07-06	MT
Lactose India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-21	CI
Lactose India Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-02-11	CI
Lactose Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-11-10	CI
Lactose Limited announced that it has received INR 12.6 million in funding	20-11-01	CI
Lactose Limited announced that it expects to receive INR 12.6 million in funding	20-10-21	CI
Lactose India Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	20-09-15	CI
Lactose India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	20-06-30	CI

Chart Lactose (India) Limited

Duration

Period

More charts

Company Profile

Lactose (India) Limited is an India-based pharmaceutical company engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products. The Company is principally engaged in the manufacturing of lactose monohydrate. The Company specializes in the manufacturing of excipients (lactose/liquid color coatings), lactulose, solid dosage forms and liquid dosage forms. It manufactures disaccharide lactulose. Lactulose is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, chronic liver disease and as an effective prebiotic. It also manufactures dry granulated, film and lacquer coated tablets. The Company is also engaged in exporting uncoated and blister packed solid dose forms. The Company's plant is located at Taluka Savli, Vadodara, Gujarat. Its lactose manufacturing facility has a capacity of 10000 metric tons/annum with an average capacity of 30 metric tons/ day.

Sector

Food Processing

Calendar

2024-08-12 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Food Processing

	1st Jan change	Capi.
LACTOSE (INDIA) LIMITED	+43.35%	26.99M
NESTLÉ S.A.	-3.95%	272B
MONDELEZ INTERNATIONAL, INC.	-9.82%	88.44B
DANONE	-0.14%	40.51B
KRAFT HEINZ	-12.98%	38.76B
THE HERSHEY COMPANY	+0.19%	37.55B
GENERAL MILLS, INC.	-3.02%	34.97B
ARCHER-DANIELS-MIDLAND COMPANY	-11.04%	31.76B
NESTLÉ INDIA LIMITED	-2.52%	30.25B
ASSOCIATED BRITISH FOODS PLC	+4.18%	23.37B